Neil McGlinchey
Overview
Explore the profile of Neil McGlinchey including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
39
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Brash L, Barnes G, Brewis M, Church A, Gibbs S, Howard L, et al.
JACC Basic Transl Sci
. 2018 Jun;
3(2):176-186.
PMID: 29876530
Apelin agonism causes systemic vasodilatation and increased cardiac contractility in humans, and improves pulmonary arterial hypertension (PAH) in animal models. Here, the authors examined the short-term pulmonary hemodynamic effects of...
2.
Panagiotou M, Vogiatzis I, Jayasekera G, Louvaris Z, Mackenzie A, McGlinchey N, et al.
Clin Physiol Funct Imaging
. 2017 Feb;
38(2):254-260.
PMID: 28168802
Background: Non-invasive methods of measuring cardiac output are highly desirable in pulmonary arterial hypertension (PAH). We therefore sought to validate impedance cardiography (ICG) against thermodilution (TD) and cardiac magnetic resonance...
3.
Panagiotou M, Vogiatzis I, Louvaris Z, Jayasekera G, McKenzie A, McGlinchey N, et al.
Eur Respir J
. 2017 Jan;
49(1).
PMID: 28052962
No abstract available.
4.
Panagiotou M, Vogiatzis I, Louvaris Z, Jayasekera G, Mackenzie A, McGlinchey N, et al.
Eur Respir J
. 2016 Sep;
48(4):1224-1227.
PMID: 27587562
No abstract available.
5.
McGlinchey N, Johnson M
Biomark Med
. 2014 Oct;
8(8):1001-11.
PMID: 25343672
Pulmonary arterial hypertension (PAH) remains a difficult-to-treat condition with high mortality. Biomarkers are utilized to aid with diagnosis, prognostication and response to treatment. A clinically useful and PAH-specific single biomarker...
6.
McGlinchey N, Peacock A
Drug Discov Today
. 2014 May;
19(8):1236-40.
PMID: 24814434
There has been substantial progress in the treatment of pulmonary arterial hypertension using specific disease-targeted therapies. As the number of agents available grows, and as new treatment strategies emerge, it...